MR-PET Imaging

PET-MRI is a new scanning test being used at NYU Medical Center primarily in the evaluation of patients with certain types of cancer including prostate cancer and metastases to bone, hepatocellular carcinoma, thyroid cancer, breast cancer, pediatric lymphoma, and brain gliomas. The images are generated from combined magnetic resonance imaging (MRI) and positron emission tomography (PET) data in order to assess certain aspects of a cancer such as size of the cancer and biochemical and molecular activity in the cancer.  The test is also useful to determine the presence and extent of metastatic disease to the rest of the body.  This information may be helpful in planning a biopsy or surgery of the cancer and potentially may help in evaluating whether a treatment is working.